Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Faron Pharmaceuticals Share Price
  4. Faron Pharmaceuticals Share Regulatory News

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Faron Pharmaceuticals Information

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

45678910111213
Date   Source Headline
21st Nov 20167:00 amRNSGrant of options
31st Oct 20167:00 amRNSNew Application Accepted by Finnish Patent Office
24th Oct 20167:00 amRNSFirst patient recruited in Japanese Ph III trial
7th Oct 20161:41 pmRNSNotification of Major Interest in Shares
6th Oct 201610:00 amRNSNotification of Major Interest in Shares
5th Oct 20165:10 pmRNSNotification of Major Interest in Shares
26th Sep 20163:59 pmRNSDirector Dealing
21st Sep 201611:27 amRNSRaises £8.0 M through a Placing and Subscription
20th Sep 20167:00 amRNSProposed Placing & Subscription to raise £8M
5th Sep 20167:00 amRNSInterim Results for six months ended 30 June 2016
10th Aug 20167:00 amRNSFaron Pharmaceuticals Notice of Interim Results
25th Jul 20167:00 amRNSFaron enters agreement with Abzena for Clevegen
22nd Jun 201612:00 pmRNSFaron to Present at Proactive Investors Forum
14th Jun 20167:00 amRNSFaron Provides Update at R&D Day
13th Jun 20167:00 amRNSFaron Licenses Traumakine Rights to Pharmbio Korea
26th May 201610:53 amRNSFaron Result of Annual General Meeting
26th May 20167:00 amRNSFaron Expands R&D Strategy for Clevegen
13th May 20167:00 amRNSFaron Pharmaceuticals Ltd to host an R&D Day
4th May 20167:00 amRNSNotice of AGM
3rd May 20167:00 amRNSFaron Appoints New Medical Director
22nd Apr 20167:00 amRNSFaron Appoints Panmure Gordon as Joint Broker
19th Apr 20167:00 amRNSFaron Files Two New Patents to Protect Clevegen
10th Mar 20167:00 amRNSAnnual Results for the year ended 31 December 2015
1st Mar 20167:00 amRNSFaron files patent application for Traumakine
10th Feb 20167:00 amRNSNotice of Preliminary Results
7th Jan 20167:00 amRNSTop-line results from Japanese study of Traumakine
29th Dec 20157:00 amRNSFirst Patient recruited in Phase III ARDS Study
21st Dec 20157:00 amRNSFaron Awarded ?1.5 million Tekes Funding
30th Nov 20157:00 amRNSKey Publication in Journal of Immunology
17th Nov 20157:30 amRNSAdmission to AIM and first day of dealings
45678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CIP
CIP.L
LSE
0.00%
WWH
Worldwide Healthcare Trust
LSE
0.59%
SVCA
Servoca
LSE
0.00%
FSV
Fidelity
LSE
0.00%
CHG
Chemring
LSE
-0.24%
Trending
MAC
Marechale Cap.
LSE
42.47%
HE1
Helium One
LSE
6.28%
ALRT
Defence Holdings
LSE
0.00%
NEO
Neo Energy Metals
LSE
-7.30%
IMM
Immupharma
LSE
-5.22%